Skip to Content

Clinically and statistically significant improvement for efgartigimod in adults with ITP

In this MEDtalk dr. Catherine, Broome, associate, professor of Medicine at Med.Star Georgetown University Hospital in Washington, present the data of efficacy and safety for intravenous efgartigimod in adults with primary immune thrombocytopenia from the ADVANCE IV study, a multi-center double-blinded placebo controlled randomized clinical trial.

Catherine Broome

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top